Obesity rates may be increasing across the nation, but some communities are managing to stay fit and active. Here are the ten fittest metro areas in America, according to Gallup’s […]

In the five years since the first DrugBaron article was published, entitled “Hard Times, Harder Times,” it seems that in the business of drug discovery and development everything has changed – […]

PARSIPPANY, NJ–(Marketwired – May 14, 2015) – Ogilvy CommonHealth Worldwide (www.ochww.com), the health behavior change experts of Ogilvy & Mather (www.ogilvy.com), and a WPP company (NASDAQ: WPPGY) (www.wpp.com), today announced […]

Shares in Orexigen Therapeutics, the maker of a weight-loss drug called Contrave, have dropped 24%  to $5 since Tuesday, when news came out that data that the drug maker had […]

Update 7:15: Click here for Orexigen’s comments on this situation. A top cardiologist is accusing a drug maker with whom he worked closely of making misleading statements about its weight loss […]

With the drug industry launching more expensive targeted therapies, the number of Americans with annual medication costs of more than $50,000 has jumped more than 60% to nearly 600,000, a […]